Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-06-16

Clinical Trial Update: Prospective Evaluation of Budesonide for Prevention of Esophageal Strictures After Endotherapy [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating budesonide to prevent esophageal strictures after endoscopic therapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Budesonide (BUDESONIDE)

Snippet

Sponsor: Mayo Clinic | Conditions: Esophageal Stricture | Phase 2 | Status: COMPLETED | Results posted: 2020-06-16